Crossref logo
Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study
Koh,Kyung-Nam et al.
Journal of Korean Medical Science(2017),32(4):642
http://dx.doi.org/10.3346/jkms.2017.32.4.642